Decision by the Danish Medicines Agency – letters sent to companies

On 11 June 2010, the Danish Medicines Agency made a decision on the future reimbursement status of medicinal products in ATC group A02 (products for acid-related disorders).

In the fact box to the right, you can find a link to the letter containing the decision which the Agency has sent to companies holding a marketing authorisation for medicinal products comprised by the decision.